- Latest week
- 10 Jul 2026
- Close
- 0.009900
- Fair value
- 0.044913
- Next-week expectancy
- Negative 26.67%
BSFA Chart Pack
BSF Enterprise Plc
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, BSFA fell 43.43%, moving from 0.02 to 0.01. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -53.16 and has softened across the 12-week window. Market Dynamics is -0.42 on the latest week. Next-week expectancy is negative at 26.67% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 0.01
- 12-Week Change
- -43.43%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 26.67%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -53.16
- Market Dynamics
- -0.42
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 0.01
- 12-Week Change
- -43.43%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 26.67%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -53.16
- Market Dynamics
- -0.42
Over the latest 12 completed weeks ending 2026-07-10, BSFA fell 43.43%, moving from 0.02 to 0.01. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -53.16 and has softened across the 12-week window. Market Dynamics is -0.42 on the latest week. Next-week expectancy is negative at 26.67% based on similar historical setup states.
Industry Peers
United Kingdom equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| IMM ImmuPharma plc | LSE | 10 Jul 2026 | 0.03 | 0.04 | 0.03 | 0.04 | 16.40% |
| IXI IXICO plc | LSE | 10 Jul 2026 | 0.08 | 0.10 | 0.08 | 0.09 | 12.12% |
| SAR Sareum Holdings plc | LSE | 10 Jul 2026 | 0.21 | 0.24 | 0.20 | 0.23 | 9.52% |
| POLB Poolbeg Pharma PLC | LSE | 10 Jul 2026 | 0.07 | 0.07 | 0.07 | 0.07 | 1.45% |
| HEMO Hemogenyx Pharmaceuticals Plc | LSE | 10 Jul 2026 | 7.71 | 8.20 | 7.11 | 7.75 | 0.52% |
| APTA Aptamer Group PLC | LSE | 10 Jul 2026 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00% |
| AREC Arecor Therapeutics plc | LSE | 10 Jul 2026 | 0.64 | 0.65 | 0.62 | 0.64 | 0.00% |
| PYC Physiomics Plc | LSE | 10 Jul 2026 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00% |
| TCF Theracryf Plc | LSE | 10 Jul 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
| THAT Thalia Therapeutics Plc | LSE | 10 Jul 2026 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00% |
| PRTC PureTech Health plc | LSE | 10 Jul 2026 | 120.60 | 124.00 | 115.00 | 120.00 | -0.50% |
| ONT Oxford Nanopore Technologies plc | LSE | 10 Jul 2026 | 121.00 | 128.70 | 111.90 | 120.30 | -0.58% |
| OPTI OptiBiotix Health Plc | LSE | 10 Jul 2026 | 0.06 | 0.07 | 0.06 | 0.06 | -0.78% |
| OXB Oxford Biomedica plc | LSE | 10 Jul 2026 | 617.00 | 623.22 | 581.00 | 611.00 | -0.97% |
| FARN Faron Pharmaceuticals Oy | LSE | 10 Jul 2026 | 0.42 | 0.43 | 0.40 | 0.42 | -1.19% |
| BVXP Bioventix PLC | LSE | 10 Jul 2026 | 1600.00 | 1650.00 | 1550.00 | 1580.00 | -1.25% |